Sanofi SA
OTC:SNYNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
OTC:SNYNF
|
FR |
|
I
|
Immutep Ltd
F:YP1A
|
AU |
|
I
|
Immutep Ltd
OTC:PRRUF
|
AU |
|
Biocon Ltd
NSE:BIOCON
|
IN |
|
I
|
Immutep Ltd
NASDAQ:IMMP
|
AU |
|
I
|
Immutep Ltd
F:YP1B
|
AU |
|
Immutep Ltd
ASX:IMM
|
AU |
Wall St Price Targets
SNYNF Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNYNF is 109.39 USD with a low forecast of 64.78 USD and a high forecast of 132.32 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNYNF's stock price target?
Price Target
109.39
USD
According to Wall Street analysts, the average 1-year price target for SNYNF is 109.39 USD with a low forecast of 64.78 USD and a high forecast of 132.32 USD.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 5%.
What is the Pre-Tax Income forecast for Sanofi SA?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 6%.
